A 12 ferroptosis-related lncRNA prognostic model for HCC stratifies patients into high-risk and low-risk groups, with the high-risk group showing elevated immune checkpoint molecule expressions (PD-1, CTLA-4, CD86). The gene discussed is CTLA4; the disease is hepatocellular carcinoma.